← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 30, 2012Last known activity
Feb 17, 2023
Timeline
2000s
- Feb 28, 2008
MiMedx Group, Inc.— Founded
Drugs by trial phase (7 distinct, 15 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT05796765Lead sponsorPhase 2Feb 17, 2023
- NCT03485157Lead sponsorPhase 2Mar 27, 2018
- NCT03479489Study directorN/AFeb 5, 2018
- NCT03479489Lead sponsorN/AFeb 5, 2018
- NCT03414255Lead sponsorPhase 3Jan 9, 2018
- NCT03414268Lead sponsorPhase 3Jan 8, 2018
- NCT03323021Lead sponsorPhase 4May 23, 2017
- NCT03074526Lead sponsorN/AJan 23, 2017
- NCT02645591CollaboratorPhase 2Nov 30, 2016
- NCT02844660Lead sponsorN/AJul 1, 2016
- NCT02768155Lead sponsorN/AApr 30, 2016
- NCT02765737Lead sponsorN/AApr 30, 2016
- NCT02768155Study directorN/AApr 30, 2016
- NCT02427191Lead sponsorPhase 2/Phase 3Mar 31, 2015
- NCT01921569Lead sponsorN/AJun 30, 2013
Details
- Founded
- Marietta, GA, US Feb 28, 2008
- Last known activity
- Feb 17, 2023